Form 4 for ISRG Intuitive Surgical
Accepted 2022-10-24 00:00:00 ET · period of report 2022-10-21 · accession 0001035267-22-000171 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-24 | 2022-10-21 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $172.35 | +8,000 | 6,217 | New | +$1.38M |
| DM | 2022-10-24 | 2022-10-21 | ISRG | Curet Myriam | EVP, Chief Medical Off | S - Sale+OE | $209.78 | -8,000 | 217 | -97% | -$1.68M |
| DM | 2022-10-24 | 2022-10-21 | ISRG | Curet Myriam | EVP, Chief Medical Off | M - OptEx | $0.00 | -8,000 | 12.0K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-21 | M | A | 2,000 | $166.62 | 2,217 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-21 | S | D | 6,000 | $209.78 | 217 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $207.08 to $212.46 as follows: 1,290 shares sold at $207.08 to $208.08; 1,411 shares sold at $208.09 to $209.09; 1,600 shares sold at $209.49 to $210.41; 3,319 shares sold at $210.50 to $211.45 and 380 shares sold at $211.70 to $212.46. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2022-10-21 | M | A | 6,000 | $174.26 | 6,217 | D | — | — | |
| 4 | Common | Common Stock | 2022-10-21 | S | D | 2,000 | $209.78 | 217 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $207.08 to $212.46 as follows: 1,290 shares sold at $207.08 to $208.08; 1,411 shares sold at $208.09 to $209.09; 1,600 shares sold at $209.49 to $210.41; 3,319 shares sold at $210.50 to $211.45 and 380 shares sold at $211.70 to $212.46. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-10-21 | M | D | 2,000 | $0.00 | 8,500 | D | $166.62 · — to 2029-08-15 | 2,000 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-10-21 | M | D | 6,000 | $0.00 | 12,000 | D | $174.26 · — to 2028-08-15 | 6,000 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |